Best Momentum Stocks to Buy for April 10th
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, April 10:
Guardian Pharmacy Services, Inc. GRDN: This pharmacy service company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.6% over the last 60 days.
Guardian Pharmacy Services, Inc. Price and Consensus
Guardian Pharmacy Services, Inc. price-consensus-chart | Guardian Pharmacy Services, Inc. Quote
Guardian Pharmacy Services’ shares gained 7.7% over the last three months compared with the S&P 500’s decline of 2.7%. The company possesses a Momentum Scoreof B.
Guardian Pharmacy Services, Inc. Price
Guardian Pharmacy Services, Inc. price | Guardian Pharmacy Services, Inc. Quote
Escalade, Incorporated ESCA: This sporting goods company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.5% over the last 60 days.
Escalade, Incorporated Price and Consensus
Escalade, Incorporated price-consensus-chart | Escalade, Incorporated Quote
Escalade’s shares gained 4.0% over the last three months compared with the S&P 500’s decline of 2.7%. The company possesses a Momentum Score of B.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check out this week’s current list of Best Stocks to Buy Now.
Learn more about the Momentum score and how it is calculated here.
Zacks Names #1 Semiconductor Stock
This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.
See This Stock Now for Free >>This article originally published on Zacks Investment Research (zacks.com).
